Richard P. Slaughter Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,024
| Closed | -$1.46M | – | 148 |
|
|
2024
Q4 | $1.46M | Sell |
15,024
-448
| -3% | -$43.6K | 0.33% | 79 |
|
|
2024
Q3 | $1.78M | Sell |
15,472
-561
| -3% | -$64.5K | 0.41% | 68 |
|
|
2024
Q2 | $1.71M | Buy |
16,033
+1,045
| +7% | +$111K | 0.4% | 62 |
|
|
2024
Q1 | $1.45M | Sell |
14,988
-443
| -3% | -$42.9K | 0.35% | 76 |
|
|
2023
Q4 | $1.56M | Sell |
15,431
-507
| -3% | -$51.2K | 0.39% | 73 |
|
|
2023
Q3 | $1.62M | Buy |
15,938
+112
| +0.7% | +$11.4K | 0.43% | 62 |
|
|
2023
Q2 | $1.6M | Sell |
15,826
-539
| -3% | -$54.4K | 0.46% | 60 |
|
|
2023
Q1 | $1.51M | Sell |
16,365
-21
| -0.1% | -$1.93K | 0.49% | 59 |
|
|
2022
Q4 | $1.49M | Buy |
16,386
+419
| +3% | +$38K | 0.47% | 65 |
|
|
2022
Q3 | $1.21M | Buy |
15,967
+813
| +5% | +$61.8K | 0.51% | 65 |
|
|
2022
Q2 | $1.28M | Buy |
15,154
+1,020
| +7% | +$86.2K | 0.56% | 64 |
|
|
2022
Q1 | $1.24M | Buy |
14,134
+1,536
| +12% | +$135K | 0.46% | 76 |
|
|
2021
Q4 | $1.1M | Sell |
12,598
-297
| -2% | -$26K | 0.39% | 90 |
|
|
2021
Q3 | $1.05M | Buy |
12,895
+1,252
| +11% | +$102K | 0.42% | 90 |
|
|
2021
Q2 | $1.06M | Sell |
11,643
-1
| -0% | -$91 | 0.41% | 84 |
|
|
2021
Q1 | $995K | Sell |
11,644
-399
| -3% | -$34.1K | 0.41% | 90 |
|
|
2020
Q4 | $1.14M | Buy |
12,043
+376
| +3% | +$35.5K | 0.48% | 60 |
|
|
2020
Q3 | $1.01M | Sell |
11,667
-1,279
| -10% | -$111K | 0.46% | 57 |
|
|
2020
Q2 | $1.13M | Buy |
12,946
+48
| +0.4% | +$4.19K | 0.49% | 58 |
|
|
2020
Q1 | $1.06M | Buy |
12,898
+557
| +5% | +$45.9K | 0.56% | 50 |
|
|
2019
Q4 | $1.17M | Buy |
+12,341
| New | +$1.17M | 0.47% | 65 |
|